CF
IONS icon

Centaurus Financial’s Ionis Pharmaceuticals IONS Stock Holding History

Centaurus Financial’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-114
Closed -$1.4K – 615
2019
Q1 		$1.4K Buy
+114
New +$7.35K 0.01% 509
2018
Q3 		– Sell
-1,400
Closed -$58K – 1268
2018
Q2 		$58K Buy
+1,400
New +$62.1K 0.01% 888

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Centaurus Financial's IONS Position: Q2 2019 in Review

Centaurus Financial sold out of Ionis Pharmaceuticals (IONS) in Q2 2019, closing a stake of 114 shares — an estimated $1.4K sold.

Centaurus Financial first reported a position in IONS in Q2 2018 and held it in 2 quarters. The position peaked at $58K in Q2 2018. 396 funds tracked by Wall St. Rank hold IONS as of Q2 2019.

  • Centaurus Financial reported no remaining Ionis Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Centaurus Financial sold 114 Ionis Pharmaceuticals shares in Q2 2019, an estimated $1.4K.
  • Centaurus Financial first reported a position in Ionis Pharmaceuticals in Q2 2018 and held it in 2 quarters.
  • Centaurus Financial's Ionis Pharmaceuticals position peaked at $58K in Q2 2018.
  • 396 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2019.

Based on Centaurus Financial's 13F filing for Q2 2019, filed 15 Aug 2019.